Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial (vol 36, pg 1428, 2018)

Armand

首页> 外文期刊>Journal of Clinical Oncology >Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial (vol 36, pg 1428, 2018)

【24h】

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial (vol 36, pg 1428, 2018)

机译：虚拟/难治性经典霍奇金淋巴瘤的Nivolumab在自体造血细胞移植失败后：延长多射游单臂第二阶段的延长随访205次试验（Vol 36，PG 1428,2018）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Clinical Oncology》 |2018年第26期|共1页
作者
Armand;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献

1. Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial (vol 36, pg 1428, 2018) [J] . Armand Journal of Clinical Oncology . 2018,第26期

机译：虚拟/难治性经典霍奇金淋巴瘤的Nivolumab在自体造血细胞移植失败后：延长多射游单臂第二阶段的延长随访205次试验（Vol 36，PG 1428,2018）
2. Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial [J] . Armand Philippe, Engert Andreas, Younes Anas, Journal of Clinical Oncology . 2018,第14期

机译：生物造血细胞移植失败后，Nivolumab进行复发/难治性经典霍奇金淋巴瘤：延长多臂单臂期II的延长随访205次试验
3. Nivolumab for Relapsed or Refractory Classical Hodgkin Lymphoma (cHL) after Autologous Hematopoietic Cell Transplantation (auto-HCT): Extended Follow-up of the Phase 2 Single-Arm CheckMate 205 Study [J] . Armand Philippe, Engert Andreas, Younes Anas, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：在自体造血细胞移植后的复发或难治性经典霍奇金淋巴瘤（CHL）的Nivolumab（Auto-Hct）：延长相2单臂的延长随访205研究
4. Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial [O] . Philippe Armand, Andreas Engert, Anas Younes, -1

机译：自体造血细胞移植失败后复发/难治性经典霍奇金淋巴瘤的Nivolumab：多队列单臂II期CheckMate 205试验的多队列扩展随访
5. Faculty Opinions recommendation of Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial. [O] . David Teachey 2021

机译：作者：王莹，王莹，王莹，王莹，王莹，王莹，王莹，王莹，王莹，王莹，王莹

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial (vol 36, pg 1428, 2018)

著录项

相似文献

相关主题

期刊订阅